New Edge Advisors, LLC Vertex Pharmaceuticals Inc Transaction History
New Edge Advisors, LLC
- $16 Billion
- Q4 2024
A detailed history of New Edge Advisors, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, New Edge Advisors, LLC holds 12,651 shares of VRTX stock, worth $6.48 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
12,651
Previous 11,357
11.39%
Holding current value
$6.48 Million
Previous $5.28 Million
3.54%
% of portfolio
0.03%
Previous 0.04%
Shares
27 transactions
Others Institutions Holding VRTX
# of Institutions
1,764Shares Held
228MCall Options Held
1.63MPut Options Held
1.47M-
Capital World Investors Los Angeles, CA28.3MShares$14.5 Billion1.8% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.3MShares$11.9 Billion0.17% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$10.9 Billion0.23% of portfolio
-
State Street Corp Boston, MA12MShares$6.14 Billion0.2% of portfolio
-
Capital Research Global Investors Los Angeles, CA10.4MShares$5.35 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $132B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...